Medistem Laboratories, Inc. (MDSM.OB) is aggressively moving forward with its stem cell therapy research.
MDSM is collaborating on pre-clinical research with...
Medistem Laboratories, Inc. (MDSM.OB) is moving forward with its second pipeline candidate known as, Tolerostem(TM).
This procedure is a cellular therapy platform aimed at controlling harmful...
The founder of Medistem Laboratories, Inc., Neil Riordan was one who identified, very early, the immense promise of stem cell therapies. From that origin, the company’s proprietary patent...
Scientists from Medistem laboratories, Inc. (MDSM) have published a peer reviewed paper outlining the practical rationale for a broader medical use of cord stem cells, without the limiting...
DALLAS--(BUSINESS WIRE)--A new research note has been issued on Medistem Laboratories, Inc.
(OTCBB: MDSM) by Beacon Equity Research Senior Research Analyst, Lisa
Springer, CFA.
...
TEMPE, Ariz.--(BUSINESS WIRE)--Sept. 15, 2006--Medistem Laboratories Inc. (OTCBB: MDSM; FWB: S2U), committed to the ethical development and commercialization of medical therapies utilizing adult...
DALLAS--(BUSINESS WIRE)--Aug. 23, 2006--A new research note has been issued on Medistem Laboratories, Inc. (OTCBB: MDSM) by Beacon Equity Research Senior Research Analyst, Shailesh Dhuri, CFA. The...
#7: MDSM News Medistem Appoints Former World Health Organization Microbiologist Dr. Clem Persaud to Medical Advisory Board; New Member Underscores Medistem's Commitment to Collaboration with International Authorities on Stem Cell Research
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Aug. 18, 2006--Medistem Laboratories, Inc. (OTCBB:MDSM) (FWB:S2U), committed to the ethical development of next-generation medical therapies from...
#6: MDSM News Web Alert: Medistem to Host Conference Call Today at 12 Noon ET to Discuss Newly Opened Stem Cell Clinic, Other News; Company CEO to Review Recent Milestones and Mission to Develop and Commercialize Stem Cell Therapies
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Aug. 14, 2006--Medistem Laboratories, Inc. (OTCBB:MDSM) (FWB:S2U), committed to the ethical development of next-generation medical therapies from...
#5: MDSM News Medistem to Hold Investor Conference Call to Discuss First Clinic Licensed to Deliver Company's Proprietary Stem Cell Treatments; CEO to Outline Progress to License Stem Cell Technology to Additional Clinics and Laboratories Worldwide
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Aug. 11, 2006--Medistem Laboratories, Inc. (OTCBB:MDSM) (FWB:S2U), committed to the ethical development of next-generation medical therapies from...
#4: MDSM News Medistem's International Affiliate ICM Granted License to Operate Adult Stem Cell Bank and Clinic; Opening of Pioneering Facility Represents Threshold Event in Medistem's Business Plan to Deliver Stem Cell Therapies
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Aug. 10, 2006--Medistem Laboratories, Inc. (OTCBB:MDSM)(FWB:S2U), committed to the ethical development of next-generation medical therapies from...
#3: MDSM News Medistem Announces Appointment of Accomplished Researcher Dr. Eduardo Glenn, as Director of New Stem Cell Lab in Costa Rica; New ICM Lab Director to Help Lead Pioneering Work Conducted at ICM Facility
SAN JOSE, Costa Rica--(BUSINESS WIRE)--Aug. 8, 2006--Medistem Laboratories, Inc. (OTCBB:MDSM)(FWB:S2U), committed to the ethical development of next-generation medical therapies from...
#2: MDSM News Medistem Files Patent Application for Stem Cell Therapy to Treat Erectile Dysfunction; Potential Therapy Designed to Reverse Multiple Causes of Erectile Dysfunction and Target $3 Billion Global Market for ED Treatments
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Aug. 4, 2006--Medistem Laboratories, Inc. (OTCBB:MDSM) (FWB:S2U), committed to the ethical development of next-generation medical therapies from...
#1: MDSM News Medistem Announces Appointment of Steven M. Rivers as Its Chief Financial Officer; Veteran Financial Professional is Named to Oversee Financial Operations of Adult Stem Cell Technology Company
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--July 5, 2006--Medistem Laboratories, Inc. (OTCBB:MDSM) (FWB:S2U), committed to the ethical development of next-generation medical therapies from...
